Redmile Group’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-96,869
Closed -$21.6M 72
2022
Q1
$21.6M Sell
96,869
-123,057
-56% -$27.6M 0.67% 41
2021
Q4
$52.2M Sell
219,926
-2,600
-1% -$607K 1.19% 26
2021
Q3
$51.9M Sell
222,526
-403
-0.2% -$84.5K 0.91% 36
2021
Q2
$45.9M Sell
222,929
-1,225
-0.5% -$252K 0.68% 43
2021
Q1
$46M Sell
224,154
-17,300
-7% -$3.65M 0.65% 47
2020
Q4
$51.8M Buy
241,454
+83,400
+53% +$16.2M 0.63% 45
2020
Q3
$28.9M Sell
158,054
-43,346
-22% -$8.16M 0.53% 48
2020
Q2
$37.1M Buy
+201,400
New +$40M 0.69% 43
2019
Q2
Sell
-51,721
Closed -$12.4M 89
2019
Q1
$12.4M Sell
51,721
-39,600
-43% -$9.5M 0.36% 52
2018
Q4
$21M Sell
91,321
-90,651
-50% -$22.3M 0.84% 39
2018
Q3
$51.5M Sell
181,972
-2,200
-1% -$644K 1.58% 22
2018
Q2
$54.1M Sell
184,172
-9,300
-5% -$2.54M 1.84% 20
2018
Q1
$48.8M Buy
193,472
+53,500
+38% +$12.6M 1.89% 18
2017
Q4
$30.2M Sell
139,972
-61,778
-31% -$12.5M 1.31% 28
2017
Q3
$37.5M Buy
201,750
+69,245
+52% +$12.1M 1.85% 16
2017
Q2
$22.9M Sell
132,505
-28,038
-17% -$4.5M 1.39% 30
2017
Q1
$24.5M Buy
+160,543
New +$23.5M 1.59% 24

Other funds holding ICUI

Redmile Group's ICUI Position: Q2 2022 in Review

Redmile Group sold out of ICU Medical (ICUI) in Q2 2022, closing a stake of 96,869 shares — an estimated $21.6M sold.

Redmile Group first reported a position in ICUI in Q1 2017 and held it in 17 quarters. The position peaked at $54.1M in Q2 2018. 258 funds tracked by Wall St. Rank hold ICUI as of Q2 2022.

  • Redmile Group reported no remaining ICU Medical position as of Q2 2022 after selling out during the quarter.
  • Redmile Group sold 96,869 ICU Medical shares in Q2 2022, an estimated $21.6M.
  • Redmile Group first reported a position in ICU Medical in Q1 2017 and held it in 17 quarters.
  • Redmile Group's ICU Medical position peaked at $54.1M in Q2 2018.
  • 258 funds tracked by Wall St. Rank held ICU Medical as of Q2 2022.

Based on Redmile Group's 13F filing for Q2 2022, filed 15 Aug 2022.